134 related articles for article (PubMed ID: 20212521)
1. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
Stokes ME; Black L; Benedict A; Roehrborn CG; Albertsen P
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):278-84. PubMed ID: 20212521
[TBL] [Abstract][Full Text] [Related]
2. First-year costs of treating prostate cancer: estimates from SEER-Medicare data.
Roehrborn CG; Albertsen P; Stokes ME; Black L; Benedict A
Prostate Cancer Prostatic Dis; 2009; 12(4):355-60. PubMed ID: 19468284
[TBL] [Abstract][Full Text] [Related]
3. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
4. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
5. Estimating the cost of cancer care in the United States: a work very much in progress.
Lipscomb J
J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
[No Abstract] [Full Text] [Related]
6. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
7. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
8. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic variation in health resource use and cost for prostate cancer.
Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
[TBL] [Abstract][Full Text] [Related]
10. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
12. How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?
Snyder CF; Frick KD; Blackford AL; Herbert RJ; Neville BA; Carducci MA; Earle CC
Cancer; 2010 Dec; 116(23):5391-9. PubMed ID: 20734396
[TBL] [Abstract][Full Text] [Related]
13. National health care costs of peripheral arterial disease in the Medicare population.
Hirsch AT; Hartman L; Town RJ; Virnig BA
Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
[TBL] [Abstract][Full Text] [Related]
14. Measuring costs: administrative claims data, clinical trials, and beyond.
Etzioni R; Riley GF; Ramsey SD; Brown M
Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
[TBL] [Abstract][Full Text] [Related]
15. The burden of illness associated with hepatocellular carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Shah S; Thompson D
J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
[TBL] [Abstract][Full Text] [Related]
16. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
17. Understanding prostate cancer spending growth among Medicare beneficiaries.
Zhang Y; Skolarus TA; Miller DC; Wei JT; Hollenbeck BK
Urology; 2011 Feb; 77(2):326-31. PubMed ID: 21168902
[TBL] [Abstract][Full Text] [Related]
18. Current prostate cancer treatments: effect on quality of life.
Gomella LG; Johannes J; Trabulsi EJ
Urology; 2009 May; 73(5 Suppl):S28-35. PubMed ID: 19375624
[TBL] [Abstract][Full Text] [Related]
19. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]